Literature DB >> 29109613

International Classification of Diseases, 10th Revision, Coding for Diabetes.

Joy Dugan1, Jay Shubrook1.   

Abstract

Entities:  

Year:  2017        PMID: 29109613      PMCID: PMC5669129          DOI: 10.2337/cd16-0052

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN: 0891-8929


× No keyword cloud information.
More than 29 million Americans have diabetes. The Centers for Disease Control and Prevention predict that the prevalence of diabetes will increase from 9% to >30% in the next 35 years (1). More than 21 million medical office visits for diabetes are scheduled each year (2). A total of one in five dollars spent on health care in the United States (and one in three dollars spent through Medicare) are spent on people with diabetes (3). With this in mind, proper and accurate coding for diabetes is a necessity. The International Classification of Diseases, 10th Revision—Clinical Modification (ICD-10) is designed to accurately classify and categorize all illnesses and diseases seen in the U.S. health care setting. (4) The coding system was updated in October 2015 to its 10th revision because it was thought that the 9th revision (ICD-9) no longer accommodated all of the new codes submitted to the system, and the ICD-9 codes were not descriptive enough to accurately reflect the state of patients’ diseases. For example, the ICD-9 system had 13,000 three- to five-digit codes. This system was not able to take in new codes and did not include a way to designate laterality. The ICD-10 system has 68,000 codes that are three to seven digits each and has the capacity to expand. In general, ICD-10 codes can be up to seven characters long and are designed as follows: XXX.XXX.X (category.anatomic site/severity.extension). The first set of digits before the first decimal point describes the general disease or category. The next three digits after the first decimal point describe the etiology, anatomical site, severity, or clinical detail. Finally, some conditions will have a second decimal point, followed by a final digit that may define an initial or subsequent encounter, the laterality of a condition, or the number of weeks’ gestation (in the case of pregnancy). This may seem overly detailed, but it allows for greater specificity of the disease and its state. Most codes for diabetes will require four or five digits to provide the level of detail required by ICD-10 (5). This article provides key updates for ICD-10 coding for diabetes and its complications. To make sense of the coding descriptions, the authors will explain them based on the way one might approach diabetes clinically.

ICD-10 Codes for Diabetes

For proper coding of diabetes, ICD-10 codes should reflect the type of diabetes, its current status, and comorbidities of the disease. Compared to ICD-9, the ICD-10 codes are much more specific. Carefully choosing the most specific ICD-10 codes is important to ensure proper reimbursement.

Codes for Screening for Diabetes or Diagnosing Prediabetes

Screening for Diabetes: Z13.1

If a person has risk factors for diabetes and you want to screen him or her for the condition (via glucose measurement, oral glucose tolerance test [OGTT], or A1C test), you would use a Z code (which indicates screening or prevention services). Alternatively, using a code that indicates the presence of a risk factor for diabetes is also acceptable for reimbursement. The current acceptable risk factors include hypertension (I10) and obesity (E66.XX).

Prediabetes Diagnosis: R73.09

If a person has prediabetes, the recommended ICD-10 code for abnormal glucose is R73.09, but this code also covers abnormal fasting glucose, abnormal glucose tolerance, or an elevated A1C in the prediabetes range (Table 1).
TABLE 1.

Diagnostic Criteria for Prediabetes* and Diabetes

NormalPrediabetesDiabetes
Fasting glucose (mg/dL)<100100–125≥126
Random glucose or OGTT (mg/dL)<140140–199≥200
A1C (%)<5.75.7–6.4≥6.5

For prediabetes, use the “abnormal glucose” code R73.09.

Diagnostic Criteria for Prediabetes* and Diabetes For prediabetes, use the “abnormal glucose” code R73.09.

Codes for Known Diabetes

When you are treating a person who has known diabetes, the first level of distinction is the type of diabetes. Under ICD-9, the main types of diabetes were coded 250.XX. To properly code for diabetes under ICD-10, four to five digits are needed. The following steps will help to ensure accurate diabetes coding.

Step 1. Confirm the Type of Diabetes

The current codes for common forms of diabetes are: Type 1 diabetes: E10.XXX Type 2 diabetes: E11.XXX Gestational diabetes mellitus (GDM): O24.429 There are a number of special categories of diabetes that have a different pathogenesis from what is known for type 1 and type 2 diabetes. These are collectively called “secondary diabetes” and should not be confused with type 2 diabetes. For secondary diabetes, use the following codes: E08.XXX: “Diabetes due to underlying condition” is for diabetes caused by diseases such as cancer, pancreatitis, or nutritional deficiencies. E09.XXX: “Drug- or chemical-induced diabetes mellitus” is for diabetes induced by a drug or toxin. E13.XXX: “Other specified diabetes mellitus” is for genetic defects of β-cell function and insulin action or post-pancreatectomy diabetes.

Step 2. Describe Whether the Person’s Diabetes Is Currently Well Controlled

Level of control is indicated by the number after the decimal point. If a person’s diabetes is well controlled, that digit will be 9 (i.e., EXX.9). For example, a person with type 2 diabetes that is well controlled who has no complications would be indicated by the code E11.9. Likewise, a person with type 1 diabetes that is well controlled who has no complications would be indicated by the code E10.9. It is important to remember that E11.9 actually describes only a minority of people with type 2 diabetes. One of the goals of ICD-10 is to better characterize the control of people with diabetes and the specifics of the complications that they are experiencing. However, many patients with diabetes have hyperglycemia, which is considered a complication. Therefore, a diagnosis code with a complication code is appropriate for the majority of people with diabetes. All of the digits beyond the decimal point are the same regardless of the type of diabetes (e.g., type 1 vs. type 2 diabetes). Each numerical code after the decimal point (numbers 1–8) describes a different complication. The second and third digit after the decimal point subcategorize that complication. For example, the most common code used for type 2 diabetes is E11.65 (type 2 diabetes with hyperglycemia), which reflects suboptimal control. The most common codes for type 1 diabetes are E10.65 (type 1 diabetes with hyperglycemia) and E10.649 (type 1 diabetes with hypoglycemia without coma).

Step 3. For Diabetes That Is Not Well Controlled, Identify Any Complications

The first digit after the decimal point describes both the level of metabolic control and the presence of complications. Further digits subcategorize the complications. As mentioned above, the number 9 after the decimal point (i.e., E10.9 or E11.9) both defines the diabetes as controlled (i.e., without hyperglycemia or hypoglycemia) and documents the absence of complications. Thus, using a 9 after the decimal point should be the exception rather than the rule, given that most people with diabetes have either suboptimal control, complications, or both. The following codes pertain to complications of type 2 diabetes: Severe hyperosmolarity: E11.0X Kidney complications: E11.2X Eye complications: E11.3X Nerve complications: E11.4X Peripheral vascular disease: E11.5X Other specified complications, including musculoskeletal, oral, and skin complications; hypoglycemia; and hyperglycemia: E11.6X Other unspecified complications: E11.8X Well-controlled type 2 diabetes without hyperglycemia, hypoglycemia, or complications: E11.9X More detailed codes further subcategorize complications. Table 2 provides ICD-10 codes for complications associated with type 1 diabetes; Table 3 lists codes for complications associated with type 2 diabetes.
TABLE 2.

Codes for Type 1 Diabetes With Complications

CodeUsed to report type 1 diabetes:
E10.1XWith the presence of diabetic ketoacidosis
 E10.10With diabetic ketoacidosis without coma
 E10.11With diabetic ketoacidosis with coma
E10.2XWith renal disease
 E10.21With diabetic nephropathy
 E10.22With diabetic chronic kidney disease
 E10.29With other diabetic kidney
E10.3XWith eye disease
 E10.311With ophthalmic complications without macular edema
 E10.319With ophthalmic complications with macular edema
 E10.321With mild nonproliferative diabetic retinopathy with macular edema
 E10.329With mild nonproliferative diabetic retinopathy without macular edema
 E10.331With macular edema
 E10.339Without macular edema
 E10.341With severe nonproliferative diabetic retinopathy with macular edema
 E10.349With severe nonproliferative diabetic retinopathy without macular edema
 E10.351With proliferative diabetic retinopathy with macular edema
 E10.359With proliferative diabetic retinopathy without macular edema
 E10.36With diabetic cataract
 E10.39With other diabetic ophthalmic complication
E10.4XWith nerve disease
 E10.40With diabetic neuropathy, unspecified
 E10.41With diabetic mononeuropathy
 E10.42With diabetic polyneuropathy
 E10.43With diabetic autonomic (poly)neuropathy
 E10.44With diabetic amyotrophy
 E10.49With other diabetic neurological complication
E10.5XWith peripheral vascular disease
 E10.51With diabetic peripheral angiopathy without gangrene
 E10.52With diabetic peripheral angiopathy with gangrene
 E10.59With other circulatory complications
E10.6XWith diabetes-related musculoskeletal, oral, or skin complications; hypoglycemia; or hyperglycemia
 E10.61With diabetic arthropathy
 E10.610With diabetic neuropathic arthropathy
 E10.618With other diabetic arthropathy
 E10.620With diabetic dermatitis
 E10.621With foot ulcer
 E10.622With other skin ulcer
 E10.628With other skin complications
 E10.630With periodontal disease
 E10.638With other oral complications
 E10.641With hypoglycemia with coma
 E10.649With hypoglycemia without coma or with hypoglycemia unawareness
 E10.65With hyperglycemia
 E10.69With other specified complication
E10.8With complications, unspecified
E10.9Without complications
TABLE 3.

Codes for Type 2 Diabetes With Complications

CodeUsed to report type 2 diabetes with:
E11.0XWith hyperosmolarity
 E11.00Without nonketotic hyperglycemic hyperosmolar coma
 E11.01With nonketotic hyperglycemic hyperosmolar coma
E11.2XWith kidney complications
 E11.21With diabetic nephropathy
 E11.22With diabetic chronic kidney disease
 E11.29With other diabetic kidney complications
E11.3XWith eye complications
 E11.31With diabetic retinopathy, unspecified
 E11.311With diabetic retinopathy with macular edema
 E11.319With diabetic retinopathy without macular edema
 E11.32With mild nonproliferative diabetic retinopathy`
 E11.321With mild nonproliferative diabetic retinopathy with macular edema
 E11.329With mild nonproliferative diabetic retinopathy without macular edema
 E11.33With moderate nonproliferative diabetic retinopathy
 E11.331With moderate nonproliferative diabetic retinopathy with macular edema
 E11.339With moderate nonproliferative diabetic retinopathy without macular edema
 E11.34With severe nonproliferative diabetic retinopathy
 E11.341With severe nonproliferative diabetic retinopathy with macular edema
 E11.349With severe nonproliferative diabetic retinopathy without macular edema
 E11.36With diabetic cataract
 E11.39With other diabetic ophthalmic complication
E11.4XWith nerve complications
 E11.40With diabetic neuropathy, unspecified
 E11.41With mononeuropathy
 E11.42With diabetic polyneuropathy
 E11.45With autonomic neuropathy (e.g., gastroparesis)
 E11.49With other diabetic neurological complications
E11.5XWith peripheral vascular disease
 E11.51With diabetic peripheral angiopathy without gangrene
 E11.52With diabetic peripheral angiopathy with gangrene
 E11.59With other circulatory complications
 E11.6XWith diabetes-related musculoskeletal, oral, or skin complications; hypoglycemia; or hyperglycemia
 E11.61With diabetic arthropathy
 E11.610With diabetic neuropathic arthropathy
 E11.618With other diabetic arthropathy
 E11.62With skin complications
 E11.620With diabetic dermatitis
 E11.621With foot ulcer
 E11.622With other skin ulcer
 E11.628With other skin complications
 E11.63With oral complications
 E11.630With periodontal disease
 E11.638With other oral complications
 E11.64With hypoglycemia
 E11.641With hypoglycemia with coma
 Ell.649Without hypoglycemia without coma
 E11.65With hyperglycemia
 E11.69With other complications
E11.8XWith other unspecified complication
E11.9XWell controlled without hyperglycemia, hypoglycemia, or complications
Codes for Type 1 Diabetes With Complications Codes for Type 2 Diabetes With Complications

Step 4. Describe Any Identified Complication

This means you will use a primary diabetes code that describes the type of diabetes, then specify whether it is controlled and whether there is a complication, and then add a second code specific to that complication. Sample codes for complications of diabetes are shown in Table 4; codes for common comorbidities are shown in Table 5.
TABLE 4.

Codes for Secondary Diagnosis for Diseases Associated With Diabetes

CodeUsed to report:
Dermatology
S81.801Open wound, unspecified, right lower leg
L97.X–L98.XSite of ulceration
L97.411Non-pressure chronic ulcer of right heel and mid-foot limited to breakdown of skin
L97.5Non-pressure chronic ulcer of other part of the foot
L97.533Non-pressure chronic ulcer of other part of left foot with necrosis of muscle
Nephrology
N18.1Chronic kidney disease (CKD) stage I
N18.2CKD stage II
N18.3CKD stage III
N18.4CKD stage IV
N18.5CKD stage V
N18.6End-stage renal disease
R80.9Microalbuminuria
Z99.2Dependence on renal dialysis
E10.42Presence of arteriovenous shunt for dialysis
Hypoglycemia
E10.649Type 1 diabetes with hypoglycemia without coma
E11.649Type 2 diabetes with hypoglycemia without coma
E08.64Diabetes due to underlying condition with hypoglycemia
E09.64Drug- or chemical-induced diabetes with hypoglycemia
E16.0Drug-induced hypoglycemia without coma
E16.1Other hypoglycemia
E16.2Hypoglycemia, unspecified
EXX.641Fill in with code for type of diabetes with hypoglycemia and coma
TABLE 5.

Codes for Common Comorbid Disease Conditions

CodeUsed to report:
F17.210Nicotine dependence, cigarettes, uncomplicated
K31.84Gastroparesis
I10Essential hypertension
Hyperlipidemia:
E78.0Pure hypercholesterolemia
E78.1Pure hypertriglyceridemia
E78.2Mixed hyperlipidemia
E78.5Hyperlipidemia, unspecified
Hypothyroidism:
E06.3Due to Hashimoto’s disease
E89.0Postoperative or postablative
E03.9Acquired
Z13.29Thyroid disorder screen
R94.6Abnormal thyroid blood test or screen
E66.0Obesity due to excess calories
E66.01Morbid severe obesity due to excess calories
E66.9Obesity, unspecified
Also utilize a Z68 code with obesity for BMI:
Z68.30BMI 30.0–30.9 kg/m2
Z68.31BMI 31.0–31.9 kg/m2
Z68.32BMI 32.0–32.9 kg/m2
Z68.33BMI 33.0–33.9 kg/m2
Z68.34BMI 34.0–34.9 kg/m2
Z68.35BMI 35.0–35.9 kg/m2
Z68.36BMI 36.0–36.9 kg/m2
Z68.37BMI 37.0–37.9 kg/m2
Z68.38BMI 38.0–38.9 kg/m2
Z68.39BMI 39.0–39.9 kg/m2
Z68.41BMI 40.0–44.9 kg/m2
Z68.42BMI 45.0–49.9 kg/m2
Z68.43BMI 50.0–59.9 kg/m2
Z68.44BMI 60.0–69.9 kg/m2
Z68.45BMI >70.0 kg/m2
G47.33Obstructive sleep apnea
E28.2Polycystic ovarian syndrome
Codes for Secondary Diagnosis for Diseases Associated With Diabetes Codes for Common Comorbid Disease Conditions

Example 1

A patient has type 2 diabetes with polyneuropathy, hypertension with albuminuria, and dyslipidemia. The coding to document this patient should be E11.65 (type 2 diabetes with hyperglycemia), E11.42 (type 2 diabetes with polyneuropathy), I10 (hypertension), R80.9 (microalbuminuria), and E78.2 (mixed hyperlipidemia).

Example 2

A patient with type 1 diabetes has an active foot ulcer on the bottom of his right foot. The coding to document this patient should be E10.621 (type 1 diabetes with foot ulcer) and L97.411 (non-pressure chronic ulcer of right heel and mid-foot limited to breakdown of skin). Comorbid conditions affect the complexity of care and the treatments you choose and thus should be coded as diagnoses. One nice feature of the BMI coding shown in Table 5 is that all BMI codes start with Z68, and the digits after the decimal are the actual BMI rounded down to the whole number. In the authors’ experience, coding obesity to the level of the BMI has improved the ability to get coverage for additional medications. This suggests that some insurers may be relying on the coding to make coverage decisions.

Codes to Document Complexity of Care Provided

Finally, there are codes that demonstrate the additional work you do or the additional complexity of the care you are providing. These codes help to justify this higher level of care. Did you provide dietary or exercise counseling? These are noted with an additional Z code: ○ Dietary counseling and surveillance: Z71.3 ○ Exercise counseling: Z71.89 Is the patient using insulin? Note that the “long-term use” code Z79.4 can be used once the drug has been initiated for any person who is taking insulin chronically. Is the patient on an insulin pump? Codes related to pump use include: Insulin pump: Z96.41 ○ Counseling, titration, removal, training, or fitting/adjustment of insulin pump: Z46.81 Insulin pump complications: T85.694 Has the patient underdosed or overdosed insulin? Codes related to these situations include: ○ Underdosing of insulin: T38.3X6 ○ Unintentional overdosing of insulin: T38.3X1 ○ Suspected self-harm by overdosing insulin: T38.3X2X After these T codes, there should be a modifier at the end to denote initial encounter (A), subsequent encounter (D), or sequalae (S). For example, an initial encounter for intentional self-harm by overdosing insulin should be “T38.3X2A.”

Codes for Pregnancy in Diabetes

Codes to report pregnancy in women with diabetes include: Preexisting type 1 diabetes in pregnancy: O24.01 Preexisting type 2 diabetes in pregnancy: O24.11 GDM, diet controlled: O24.410 GDM, insulin controlled: O24.414 Obesity complicating pregnancy, unspecified: O99.210

Conclusion

Remember the following steps when coding for patients with diabetes: Document the type of diabetes they have. Document if their diabetes is controlled without any complications. If their diabetes is uncontrolled or they have any complications, document the complications using the codes that fall to the right of the decimal point. Add the secondary diagnosis code to support the diabetes code. Box 1 offers two case studies to help you apply your knowledge of diabetes coding. Box 2 provides information about additional tools to help providers with ICD-10 coding. BOX 1. Case Studies for Diabetes Coding E10.65: Type 1 diabetes with hyperlgycemia E10.43: Type 1 diabetes with gastroparesis (autonomic neuropathy) E10.329: Type 1 diabetes with nonproliferative retinopathy E10.649: Type 1 diabetes with hypoglycemia E10.22: Type 1 diabetes with CKD stage 1 K31.84: Gastroparesis Z71.3: Dietary counseling Z79.4: Insulin use E11.65: Type 2 diabetes with hyperglycemia E11.22: Type 2 diabetes with CKD N18.3: CKD stage 3 E78.2: Mixed hyperlipidemia I10: Essential hypertension Z79.4: Insulin use Z68.37: Obesity BOX 2. Tools to Help Providers With ICD-10 Coding In many electronic health record systems, providers can type in a description of a condition in words and receive a list of codes from which to choose. Some systems allow providers to type in an outdated ICD-9 code and then provide the corresponding current ICD-10 code. There are a number of online tools that can help with coding. Among them are: ○ Centers for Medicare & Medicaid Services websites: https://www.cms.gov/medicare/coding/icd10/2015-icd-10-cm-and-gems.html and https://www.cms.gov/medicare/coding/icd10/providerresources.html ○ The ICD-10 website: https://www.ICD10data.com

BOX 1. Case Studies for Diabetes Coding

Case 1: The patient is a 45-year-old man who has had type 1 diabetes for 25 years. At today’s visit, he is diagnosed with gastroparesis. He reports one hypoglycemic episode with a random glucose of 43 mg/dL. His A1C is 7.4%. The patient has a history of nonproliferative retinopathy and CKD stage 1. You provide dietary counseling during the visit. What codes would you use?
Answer:

E10.65: Type 1 diabetes with hyperlgycemia

E10.43: Type 1 diabetes with gastroparesis (autonomic neuropathy)

E10.329: Type 1 diabetes with nonproliferative retinopathy

E10.649: Type 1 diabetes with hypoglycemia

E10.22: Type 1 diabetes with CKD stage 1

K31.84: Gastroparesis

Z71.3: Dietary counseling

Z79.4: Insulin use

Case 2:The patient is a 53-year-old obese man (BMI 37 kg/m2) who has uncontrolled type 2 diabetes with A1C of 8.8%, CKD stage 3, controlled hypertension on an ACE inhibitor, and mixed hyperlipidemia. He takes daily insulin injections. What codes would you use?
Answer:

E11.65: Type 2 diabetes with hyperglycemia

E11.22: Type 2 diabetes with CKD

N18.3: CKD stage 3

E78.2: Mixed hyperlipidemia

I10: Essential hypertension

Z79.4: Insulin use

Z68.37: Obesity

BOX 2. Tools to Help Providers With ICD-10 Coding

In many electronic health record systems, providers can type in a description of a condition in words and receive a list of codes from which to choose. Some systems allow providers to type in an outdated ICD-9 code and then provide the corresponding current ICD-10 code.

There are a number of online tools that can help with coding. Among them are:

○ Centers for Medicare & Medicaid Services websites: https://www.cms.gov/medicare/coding/icd10/2015-icd-10-cm-and-gems.html and https://www.cms.gov/medicare/coding/icd10/providerresources.html

○ The ICD-10 website: https://www.ICD10data.com

  1 in total

1.  Economic costs of diabetes in the U.S. in 2012.

Authors: 
Journal:  Diabetes Care       Date:  2013-03-06       Impact factor: 19.112

  1 in total
  7 in total

1.  Trends and Variations in Emergency Department Use Associated With Diabetes in the US by Sociodemographic Factors, 2008-2017.

Authors:  Tegveer S Uppal; Puneet Kaur Chehal; Gail Fernandes; J Sonya Haw; Megha Shah; Sara Turbow; Swapnil Rajpathak; K M Venkat Narayan; Mohammed K Ali
Journal:  JAMA Netw Open       Date:  2022-05-02

2.  Trends and Demographic Disparities in Diabetes Hospital Admissions: Analyses of Serial Cross-Sectional National and State Data, 2008-2017.

Authors:  Sara D Turbow; Tegveer S Uppal; J Sonya Haw; Puneet Chehal; Gail Fernandes; Megha Shah; Swapnil Rajpathak; Mohammed K Ali; K M Venkat Narayan
Journal:  Diabetes Care       Date:  2022-06-02       Impact factor: 17.152

3.  Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.

Authors:  Scott W Woods; Carrie E Bearden; Fred W Sabb; William S Stone; John Torous; Barbara A Cornblatt; Diana O Perkins; Kristin S Cadenhead; Jean Addington; Albert R Powers; Daniel H Mathalon; Monica E Calkins; Daniel H Wolf; Cheryl M Corcoran; Leslie E Horton; Vijay A Mittal; Jason Schiffman; Lauren M Ellman; Gregory P Strauss; Daniel Mamah; Jimmy Choi; Godfrey D Pearlson; Jai L Shah; Paolo Fusar-Poli; Celso Arango; Jesus Perez; Nikolaos Koutsouleris; Jijun Wang; Jun Soo Kwon; Barbara C Walsh; Thomas H McGlashan; Steven E Hyman; Raquel E Gur; Tyrone D Cannon; John M Kane; Alan Anticevic
Journal:  Schizophr Res       Date:  2020-05-10       Impact factor: 4.662

4.  A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury.

Authors:  Drew Watson; Joshua Y C Yang; Reuben D Sarwal; Tara K Sigdel; Juliane M Liberto; Izabella Damm; Victoria Louie; Shristi Sigdel; Devon Livingstone; Katherine Soh; Arjun Chakraborty; Michael Liang; Pei-Chen Lin; Minnie M Sarwal
Journal:  J Clin Med       Date:  2019-04-12       Impact factor: 4.241

5.  Estimating the disease burden of Korean type 2 diabetes mellitus patients considering its complications.

Authors:  Juyoung Kim; Seok-Jun Yoon; Min-Woo Jo
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

6.  Real-world evidence of the effectiveness on glycaemic control of early simultaneous versus later sequential initiation of basal insulin and glucagon-like peptide-1 receptor agonists.

Authors:  Julio Rosenstock; Francisco Javier Ampudia-Blasco; Robert Lubwama; Xuejun Victor Peng; Anders Boss; Lizheng Shi; Vivian Fonseca
Journal:  Diabetes Obes Metab       Date:  2020-09-02       Impact factor: 6.577

7.  Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors vs. Dipeptidyl Peptidase-4 Inhibitors in Frail People With Diabetes Who Were Recently Hospitalized.

Authors:  Stephen J Wood; J Simon Bell; Dianna J Magliano; Jonathan E Shaw; Matteo Cesari; Jenni Ilomaki
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.